List view / Grid view
23 June 2016 | By Victoria White, Digital Content Producer
Scientists have developed a magnetically controlled drug that can be condensed on a blood clot by means of a magnetic field...
23 June 2016 | By Victoria White, Digital Content Producer
Mucosal associated invariant T-cells (MAIT cells) could be twice as important as previously thought, according to Oxford University researchers...
23 June 2016 | By Victoria White, Digital Content Producer
Amgen has announced a five-year, platinum sponsorship of the QB3@953 life sciences incubator to accelerate the development of new therapies...
22 June 2016 | By Victoria White, Digital Content Producer
Four cancer centres in the US are coming together in a new consortium to accelerate the discovery and development of novel cancer therapeutics...
22 June 2016 | By Victoria White, Digital Content Producer
Pluristem Therapeutics has reported positive data from preclinical studies of its PLX-PAD cells in the treatment of Duchenne muscular dystrophy...
22 June 2016 | By Victoria White, Digital Content Producer
TB Alliance and Takeda are to explore hits generated from a high-throughput screening programme conducted to find novel compounds to treat tuberculosis...
21 June 2016 | By Victoria White, Digital Content Producer
A study has found that the inflammation of mosquito bites helps a virus establish an infection in the body more quickly...
21 June 2016 | By Victoria White, Digital Content Producer
A Penn Medicine preclinical study shows how an antibody - carbohydrate combination CAR T cell therapy could apply to range of cancer types...
21 June 2016 | By Victoria White, Digital Content Producer
NIH and Fiocruz have begun a study to evaluate the health risks that Zika virus infection poses to pregnant women and their developing foetuses...
21 June 2016 | By Victoria White, Digital Content Producer
Professor Andrew Tobin from the University of Leicester has discussed how remaining in the EU can help address some of the largest biomedical challenges...
21 June 2016 | By Victoria White, Digital Content Producer
In an experimental model of Wilson's disease, the peptide, called methanobactin, has already proven superior to conventional medicines...
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed an innovative nanoplatform that allows them to effectively deliver RNAi agents to the sites of cancer and suppress tumour growth...
20 June 2016 | By Victoria White, Digital Content producer
F2G Ltd has raised $60 million in financing to develop its pipeline of novel therapies to treat life threatening invasive fungal infections...
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
20 June 2016 | By Victoria White, Digital Content Producer
The new findings on thalidomide, from researchers at the Technical University of Munich (TUM), are highly relevant to current cancer therapies...
